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Abstract
The quality of DNA-labeled affinity probes is critical in DNA-assisted protein analyses, such as proximity ligation and
extension assays, immuno-PCR, and immuno-rolling circle amplification reactions. Efficient, high-performance methods are
therefore required for isolation of pure conjugates from reactions where DNA strands have been coupled to antibodies or
recombinant affinity reagents. Here we describe a universal, scalable approach for preparing high-quality oligonucleotide-
protein conjugates by sequentially removing any unconjugated affinity reagents and remaining free oligonucleotides from
conjugation reactions. We applied the approach to generate high-quality probes using either antibodies or recombinant
affinity reagents. The purified high-grade probes were used in proximity ligation assays in solution and in situ,
demonstrating both augmented assay sensitivity and improved signal-to-noise ratios.
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Introduction
DNA-assisted protein analysis technologies play an increasing
role in analyses of proteomes [1], and for disease diagnosis,
prognosis [2] and personalized medicine [3]. For optimal
performance of such analyses, high-quality and pure DNA-
coupled affinity binders are required. A broad variety of methods
are available for protein-DNA conjugation, in order to functio-
nalize antibodies for DNA-assisted protein analysis. Commonly,
biotinylated antibodies are coupled with oligonucleotide-modified
streptavidin molecules. Alternatively, bifunctional cross-linkers can
be used to covalently link antibodies to oligonucleotides with
suitable chemical modifications. For instance, primary amines of
antibodies can be reacted with dibenzylcyclooctyne-NHS esters to
allow copper-free click chemistry to attach azide-modified
oligonucleotides to the alkyne-functionalized antibodies [4].
Recently, the growing availability of new classes of affinity binders
prepared by recombinant techniques, such as recombinant
antibody fragments [5], affibodies [6] and designed ankyrin repeat
proteins (DARPins) [7], greatly increases opportunities for DNA-
assisted protein analysis. By expressing recombinant binders in
fusion with SNAP protein domains, O6-benzylguanine (BG)-
modified oligonucleotide can be covalently coupled to SNAP
domains of the affinity reagents [8]. The use of suitably modified
recombinant affinity reagents has the virtue that oligonucleotides
can be attached to the recombinant binder at a specific site,
remotely from the target binding area, and at a one-to-one (or any
other desired) stoichiometry.
In the various conjugation methods, the efficiency of functio-
nalization of affinity binders is usually maximized by employing a
large excess of suitably modified oligonucleotides, thereby
generating a mixture of the desired conjugates and an excess of
free oligonucleotides, along with any remaining unconjugated
affinity binders. In DNA-assisted protein analysis, remaining free
oligonucleotides are liable to cause target-independent detection
signals, increasing assay background. This is particularly delete-
rious in homogeneous assays where no washing steps are applied,
such as in solution phase proximity ligation assays (PLA) [9,10] or
proximity extension assays (PEA) [11]. Any unconjugated binders
in the detection reactions, be it antibodies or alternative scaffolds,
also tend to compromise assay performance by competing with
properly functionalized affinity reagents for binding to the
respective targets, resulting in reduced detection signals. Present
protocols for purifying conjugates may remove either free
oligonucleotides or antibodies, but there is a need for a general
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and convenient procedure to avoid both contaminating species in
one simple procedure [12].
We present in this study a general and efficient approach for
purification of high-quality DNA-coupled affinity binders from
free oligonucleotides and remaining unconjugated natural anti-
bodies or alternative binding scaffolds. Alkyne-modified antibodies
and azide-modified oligonucleotides were conjugated by click
chemistry, and recombinant DARPin affinity reagents were
coupled with BG-activated oligonucleotides via SNAP domains.
The conjugation reaction mixtures were subjected to solid-phase
purification, where unconjugated binders and excess oligonucle-
otides were removed in two sequential steps. The purified DNA-
labeled affinity reagents were then used in solution phase and
in situ PLA to validate the effect of the conjugation and
purification protocol on sensitivity and signal-to-noise for the
two assays.
Materials and Methods
Affinity binders, recombinant proteins and
oligonucleotides
Goat anti-human IL8 (AF-208-NA) and recombinant human
IL8 (208-IL-010) were purchased from RnD Systems. Anti-HER2
DARPins 9.01 and G3, in fusion with both an N-terminal RGS
His-tag and a C-terminal SNAP domains, referred to as 9.01-
SNAP and G3-SNAP, respectively, were expressed and prepared
as described previously [13]. Oligonucleotides with suitable
modifications (Table S1) were purchased from Integrated DNA
Technology.
Cell culture
The HER2-expressing human ovarian cancer cell line SK-OV-
3 ((HTB-77; ATCC)) was grown in RPMI1640 medium, and the
human fibroblast cell line BJhTERT was grown in Minimum
Essential Medium (MEM). Both media were supplemented with
10% fetal bovine serum (FBS), 2 mM L-glutamine and 1%
penicillin-streptomycin (all reagents from Sigma-Aldrich). The
cells were cultured at 37uC in a humidified 5% CO2 environment.
Preparation of antibody-DNA conjugates
Ten ml of antibodies (2 mg/ml reconstituted in PBS) were
activated at room temperature (RT) for 30 min with a 20-fold
molar excess of dibenzylcyclooctyne-NHS ester (DBCO-NHS
ester, CLK-A102N, Jena Bioscience; 0.67 ml of a 4 mM solution of
DBCO-NHS ester freshly dissolved in DMSO). The DBCO-
Figure 1. Schematic illustration of two-step purification of affinity binder-oligonucleotide conjugates. (a) Antibody-DNA conjugates
illustrated here as an example. Conjugation of antibodies and oligonucleotides yields a mixture of desired conjugates, along with unconjugated
antibodies and unconjugated oligonucleotides. (A) Biotinylated capture DNA oligonucleotides are hybridized to the oligonucleotides in the mixture.
(B) Streptavidin-coated Sepharose beads are used to capture the biotinylated capture oligonucleotides, both in the form of conjugates and free
oligonucleotides. (C) The unconjugated antibodies are removed by washes. (D) The MlyI enzyme is used to cleave the captured oligonucleotide
hybrids, allowing both conjugates and oligonucleotides to be eluted from the solid support. (E) The eluate is then incubated either with protein G
beads (for antibody-DNA conjugates) or with Dynabeads His tag (for DARPin-DNA conjugates), while free oligonucleotides are removed by washes.
(F) Finally, purified conjugates are eluted from the solid support. (b) Illustration of hybridization of Arm1_long and Arm1 Capture, and the subsequent
MlyI cleavage.
doi:10.1371/journal.pone.0108061.g001
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activated antibodies were purified over a Zeba spin desalting
column (7K MWCO, Thermo Scientific) to remove unreacted
DBCO-NHS ester. After purification, the activated antibodies
were mixed with a 4-fold molar excess of the azide modified
oligonucleotides (Arm1_long, Arm2_long, Arm1, or Arm2, Table
S1) and incubated overnight at 4uC.
Preparation of DARPin-DNA conjugates
Thirty ml of 200 mM 59-aminohexyl modified oligonucleotides
(S3primer_long, S3block_long, S3primer and S3block, Table S1)
were incubated for 2 h at 37uC with a 30-fold molar excess of an
amino-reactive bifunctional cross-linker to functionalize the
oligonucleotides with a benzylguanine (BG) moiety (BG-GLA-
NHS (S9151S, NEB); 18 ml of a 10 mM solution BG-GLA-NHS
freshly dissolved in DMSO). Excess BG-GLA-NHS was removed
by separation through two 7K MWCO Zeba spin desalting
columns, and the purified BG-modified oligonucleotides were
collected. The DARPins 9.01-SNAP and G3-SNAP were reduced
to activate the cysteine residue within the SNAP domain in
20 mM DTT for 1 h at 37uC, separately. The reduced DARPins
were then mixed with a 3-fold molar excess of the purified BG-
modified oligonucleotides, and incubated for 1 h at 37uC.
Two-step purification of conjugates
To remove unconjugated protein, biotinylated capture oligo-
nucleotides were added at a 2-fold molar excess over the partially
complementary conjugation oligonucleotides (Arm1Capture for
Arm1_long, Arm2Capture for Arm2_long or S3Capture for both
S3primer_long and S3block_long) to the respective antibody- or
DARPin-oligonucleotide conjugates, followed by incubation for
30 min at RT. The solution was then incubated for 30 min at RT
with Streptavidin Sepharose High Performance (17-5113-01, GE
Healthcare) using 150 nmol biotinylated capture oligonucleotides
per milligram beads. After two washes with PBST (PBS containing
0.05% Tween 20) to remove unconjugated protein, 50 ml of
enzymatic elution solution (16NEB buffer 4, 1 mg/ml BSA, and
1 U/ml of the restriction enzyme MlyI (R0610S, NEB)) was added
to the streptavidin Sepharose and incubated overnight at 37uC.
Next, for antibody-DNA conjugates, the supernatant from the
MlyI cleavage was incubated with Dynabeads Protein G (10004D,
Life Technologies) for 1 h at RT, followed by two washes with
PBST to remove unconjugated oligonucleotides. The antibody-
DNA conjugates were then eluted by incubating with 50 mM
glycine-HCl (pH 2.5) for 5 min at RT and the eluate was
immediately adjusted to pH 7 with Tris buffer (pH 8.2).
For DARPin-DNA conjugates, the supernatant from the MlyI
cleavage was incubated in phosphate buffer (0.1 M phosphate, 0.5
M NaCl and 0.05% Tween 20, pH 8.3) with DynabeadsH His-Tag
Isolation and Pulldown (10103D, Life Technologies) for 1 h at
RT. The DARPin-DNA conjugates were washed three times in
PBS to remove unconjugated oligonucleotides, and then eluted
with 0.1 M imidazole in PBS for 5 min at RT.
The conjugates were quantified using the Quant-it protein assay
kit (Q33210, Life Technologies), and analyzed by electrophoresis
Figure 2. Gel electrophoresis of samples undergoing two-step purification. (a) Polyacrylamide gel of samples from purification of antibody-
DNA conjugates and controls. Lane 1: PageRuler protein ladder (10–170 kDa, Thermo Scientific), Lane 2: 50 bp DNA ladder (Thermo Scientific), Lane 3:
Arm1_long oligonucleotides (54 bp), Lane 4: Arm1 oligonucleotides (35 bp), Lane 5: anti-IL8 antibodies, Lane 6: conjugation reaction mixture of anti-
IL8 and Arm1_long, Lane 7: conjugation reaction mixture of anti-IL8 and Arm1, Lane 8: eluate of captured sample of lane 6 after MlyI cleavage, Lane 9:
anti-IL8 conjugates after two-step purification. The gel was stained with PlusOne DNA Silver Staining Kit. (b) Polyacrylamide gel of samples from
purification of DARPin-DNA conjugates and controls. Lane 1: PageRuler protein ladder, Lane 2: 50 bp DNA ladder, Lane 3: S3block_long
oligonucleotides (51 bp), Lane 4: S3block oligonucleotides (29 bp), Lane 5: G3-SNAP (34.5 kDa), Lane 6: conjugation reaction mixture of G3-SNAP and
S3block_long, Lane 7: conjugation reaction mixture of G3-SNAP and S3block, Lane 8: eluate of sample of lane 6 after MlyI cleavage, Lane 9: G3-SNAP
conjugates after the two-step purification. Relevant protein and DNA sizes are indicated. The gel was stained with Silver Stain for Mass Spectrometry
kit.
doi:10.1371/journal.pone.0108061.g002
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in GeneGel Excel 12.5/24 Kit (17-6000-14, GE Healthcare) at a
current of 25 mA for 70 min. The gels were stained with either
PlusOne DNA Silver Staining Kit (12-1150-01, GE Healthcare) or
Pierce Silver Stain for Mass Spectrometry kit (24600, Thermo
Scientific). After quantification and gel analysis the conjugates
were supplemented with 0.1% BSA and 0.05% NaN3 and stored
at 4uC.
Table 1. Summary of solution phase PLA for detection of IL8 proteins in PLA buffer or in 10% or 50% chicken serum.
Probes Matrices R2 LOD (pM) Background Ct Background CV%
Unpurified Buffer 0.9773 0.97 31.39 14.1%
Purified Buffer 0.9999 0.06 35.43 9.0%
Purified 10% Chicken serum 0.9969 0.26 34.87 13.7%
Purified 50% Chicken serum 0.9921 0.17 34.62 19.5%
R2 is the correlation coefficient of the fitting curve from 100 pM to 0.16 pM. Background Ct equals the average Ct from quadruplicates of sample in reactions with no
spiked IL8. Background CV% is the coefficient of variation calculated from the background Ct values for all quadruplicates.
doi:10.1371/journal.pone.0108061.t001
Figure 3. Solution phase PLA for detection of recombinant human IL8. (a) Detection of IL8 in PLA buffer with 60 pM pure anti-IL8 DNA
conjugates (diamonds) and 60 pM unpurified anti-IL8 DNA conjugates (squares). (b) Detection of IL8 in PLA buffer (diamonds), 10% chicken serum
(squares) and 50% chicken serum (triangles) using 60 pM pure anti-IL8 DNA conjugates. (c) Different amounts of unconjugated anti-IL8 (at a final
concentration from 480 pM to 0 pM) were spiked in 60 pM of pure anti-IL8 conjugates. This series of mixes of probes were used in samples with either
10 pM or 0 pM IL8 in PLA buffer. (d) Different amounts of unconjugated oligonucleotides (Arm1 and Arm2 at a final concentration from 120 pM to 0
pM) were spiked in 60 pM of pure anti-IL8 conjugates. The probe mixes were employed in samples with 100 pM or 0 pM IL8 in PLA buffer. Error bars
(a and b) indicate standard deviation from quadruplicate reactions and error bars (c and d) indicate standard deviation from duplicate reactions.
doi:10.1371/journal.pone.0108061.g003
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Figure 4. Detection of HER2 proteins using immuno-RCA and in situ PLA in fixed cells. (a) 5 nM pure G3-SNAP conjugates and 5 nM
unpurified G3-SNAP conjugates were separately used in immune-RCA to detect HER2 proteins in HER2-positive (SK-OV-3) or -negative (BJhTERT) cells.
Red dots represent RCA products arising from immuno-RCA reactions detected with fluorescence labeled complementary oligonucleotides. The
numbers of RCA products per cell from those images are shown in bar charts (b). (c) Boxplots present the numbers of RCA products per cell when
mixes of pure G3-SNAP conjugates (5 nM) and different amounts of unconjugated G3-SNAP (from 0 nM to 320 nM) were used to detect HER2
proteins via immuno-RCA in SK-OV-3 cells. (d) Boxplots reflect the number of RCA products per cell after in situ PLA for detection of HER2 protein in
SK-OV-3 cells, probed with pure probe conjugates (20 nM G3-SNAP conjugates and 20 nM 9.01-SNAP conjugates), mixed with different amounts of
unconjugated DARPin binders (G3-SNAP and 9.03-SNAP at concentrations of 0 nM or 20 nM). The cell nuclei were counterstained with DAPI (blue).
doi:10.1371/journal.pone.0108061.g004
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Solution phase PLA
Recombinant human IL8 was serially diluted in PLA buffer
(1 mM D-biotin (Life Technologies), 0.1% BSA (Sigma-Aldrich),
0.05% Tween 20, 100 nM goat IgG (Sigma-Aldrich), 0.1 mg/ml
salmon sperm DNA (Life Technologies), 5 mM EDTA in PBS), or
in either 10% or 50% chicken serum prepared in PLA buffer.
Individual dilution series included a negative control with no
spiked antigen. Two ml of each sample were mixed with 2 ml of 60
pM PLA probes (either purified anti-IL8-Arm1_long and anti-IL8-
Arm2_long conjugates, unpurified anti-IL8-Arm1 and anti-IL8-
Arm2 conjugates, or a pair of purified conjugates with spiked-in
anti-IL8 or Arm1 and Arm2, respectively) and incubated for 1.5 h
at RT. After incubation, 1 ml of the mixture was transferred to
25 ml ligation and quantitative PCR mixture (16 PCR buffer
(Quanta Biosciences), 2.5 mM MgCl2 (Quanta Biosciences), 0.56
Sybr Green I (Life Technologies), 0.1 mM BioFwd primer, 0.1 mM
BioRev primer, 0.025 mM BioSplint, 0.08 mM ATP (Thermo
Scientific), 0.2 mM dNTPs (with dUTP) (Thermo Scientific), 0.03
U/ml AccuStart Taq DNA polymerase (Quanta Biosciences), 0.01
U/ml T4 DNA ligase (Thermo Scientific) and 0.002 U/ml Uracil
N-glycosylase (Thermo Scientific)). Quantitative PCR was per-
formed in an MX3005 cycler (Stratagene) with an initial
incubation at 95uC for 2 min, followed by 40 cycles of 95uC for
15 sec and 60uC for 1 min.
Readout and data analysis of solution phase PLA
The results of solution phase PLA with real-time PCR readout
were recorded using the MxPro software (Stratagene) and the
cycle of threshold (Ct) was exported to Excel 2007 (Microsoft). The
plots of data were either prepared in Excel 2007 (Microsoft) or
using the statistical computing environment ‘‘R’’ (Bell Laborato-
ries). The LOD was defined as the concentration of protein
corresponding to a Ct value two standard deviations above the
average assay background. The amplification template numbers N
were calculated from Ct values using N=2402Ct, assuming that
the Ct value for one molecule of template was 40. Coefficients of
variation (CV) were calculated as CV%=StDev (N)/mean
(N)6100%, where StDev and mean is the standard deviation
and mean of quadruplicates of each sample.
In situ PLA and immuno-RCA
Ten thousand SK-OV-3 cells were seeded per well on Lab-Tek
Chamber Slides (154534, Thermo Scientific), and cultivated
overnight. Cells were fixed with 3.7% paraformaldehyde for
30 min and permeabilized in PBS containing 0.1% Triton X-100
for 15 min. To block unspecific binding of the probes 16blocking
buffer (Olink Bioscience) was added to the cells and incubated for
1 h at 37uC. The blocking buffer was replaced by 40 ml of the
purified and unpurified probes (20 nM of each purified 9.01-
SNAP-S3primer_long and G3-SNAP-S3block_long conjugates for
PLA; 5 nM of purified G3-SNAP-S3block_long conjugates and
unpurified G3-SNAP-S3block conjugates for immuno rolling
circle amplification (RCA)), diluted in the diluent buffer (Olink
Bioscience). The probes solution was incubated with the cells for
1.5 h at 37uC, followed by two washes with washing buffer
(DUO82049, Olink Bioscience). In situ PLA detection was then
completed using the Duolink in situ detection kit Orange
(excitation 554 nm/emission 576 nm, DUO92007, Olink Biosci-
ence). For immuno-RCA the incubation with G3-SNAP conju-
gates was followed, after two washes, by a step where a 40 ml
ligation mix (40 mM Tris-HCl, 10 mM MgCl2, 0.1 mM ATP,
100 nM S3 padlock oligonucleotide and 0.02 U/ml T4 DNA
ligase (Thermo Scientific)) was added for a 30 min incubation at
37uC. After ligation and two washes, 40 ml amplification and
detection mix (Duolink in situ detection kit Orange, DUO92007,
Olink Bioscience) was applied to complete the immuno-RCA
detection. Next, all slides were incubated with 1.25 mg/ml
Hoechst 33342 (Life Technologies) for 20 min at RT to
counterstain cell nuclei. The slides were then washed twice for
10 min in 16 buffer B (DUO82049, Olink Bioscience), followed
by a 1 min wash step in 0.016 buffer B and mounting with
Vectashield (H-1000, Vector Labs). In parallel, the cells on slides
were analyzed with in situ PLA using 20 nM of pure G3-SNAP
and 9.01-SNAP probes spiked with 20 nM of unconjugated G3-
SNAP and 9.01-SNAP. The cells were also detected with immuno-
RCA using 5 nM of G3-SNAP probe spiked with unconjugated
G3-SNAP at different concentrations (40, 80, 160 or 320 nM).
Imaging and data analysis
Cell images were acquired using an Axioplan 2 epifluorescence
microscope (Zeiss), equipped with a 100 W mercury lamp, a
cooled CCD camera (AxioCam HRm, Zeiss), a computer-
controlled filter wheel with excitation and emission filters for
visualization of DAPI (excitation 350 nm/emission 470 nm) and
Cy3 (excitation 550 nm/emission 570 nm), and a 206 objective
(Plan-Apochromat 440640-9903, Zeiss). Images were collected as
compilations of Z-stacks and processed with AxioVision software
(version 4.8, Zeiss). Image analysis and quantification of RCA
products were conducted with the Duolink Image Tool
(DUO90806, Olink Biosciences).
Results and Discussion
The general approach to prepare high-grade DNA-labeled
affinity binders is schematically illustrated in Figure 1, exemplified
with the preparation of antibody-oligonucleotide conjugates. First,
the conjugation was performed in solution by mixing DBCO-
modified antibodies with a 4-fold molar excess of azide-modified
oligonucleotides. After incubation, the resulting mix containing
antibody-DNA conjugates and remaining free antibodies and
oligonucleotides, was incubated with biotinylated capture oligo-
nucleotides at 2-fold molar excess over conjugation oligonucleo-
tides, and the products were immobilized on streptavidin-coated
Sepharose beads. After washes to remove unconjugated antibod-
ies, the captured antibody-DNA conjugates along with unconju-
gated oligonucleotides were both released by enzymatic cleavage
using the restriction enzyme MlyI that cleaves at the border of the
complementary region between the capture and conjugate
oligonucleotides (Fig. 1b) to release single-stranded DNA-coupled
conjugates. The eluate was then captured on protein G beads and
washes were conducted to remove any free oligonucleotides having
no antibodies attached. Finally, purified conjugates were eluted
from the protein G beads by lowering the pH.
In order to monitor the purification and MlyI cleavage steps,
the antibodies were also conjugated separately to two shorter
oligonucleotides (Arm1 and Arm2) corresponding precisely to the
cleaved form. When these conjugates with shorter oligonucleotides
were electrophoresed, they resulted in bands of identical molecular
weight as the conjugates released by restriction digestion.
The conjugation reaction mixtures, the eluates after enzymatic
cleavage, and the purified conjugates were all analyzed by
polyacrylamide gel electrophoresis and visualized with silver
staining (Figure 2a). The conjugation reaction mixtures (lanes 6
and 7) resulted in a smear of bands similar to and larger than
unconjugated antibodies (around 150 kDa, lane 5) and bands at
the bottom of the gel corresponding to sizes of unconjugated DNA
oligonucleotides (lane 3 and 4). After MlyI cleavage and elution,
the cleaved excess oligonucleotides in the eluate from antibodies
High-Quality Reagents Preparation for DNA-Assisted Protein Analysis
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conjugated to Arm1_long (lane 8) migrated similarly to Arm1 (lane
4), which corresponds to the length of the cleaved products. This
indicates that the MlyI cleavage works efficiently on the solid
support. Under the native conditions that the samples were
electrophoresed, the migration of conjugated antibodies in lanes 8
and 9 (around 170 kDa or larger) was only slightly slower than
that of unconjugated antibodies (around 150 kDa, lane 5). After
the whole purification protocol (Fig. 1) the oligonucleotides
observed in the reaction mixture at the bottom of lane 8 were
completely removed, and pure antibody-DNA conjugates were
obtained and visualized (lane 9). The yield for antibody conjugates
after the two-step purification was approximately 20% of the
starting antibody input.
To investigate if a variation of the purification method would
also be suitable for recombinant affinity reagents, a procedure
similar to the one described above was performed for DARPin-
SNAP constructs (HER2-specific G3-SNAP and 9.01-SNAP)
[14,15]. DARPins were expressed in fusion with a His-tag and a
SNAP protein domain, allowing the convenient conjugation and
purification of the DARPins. After reduction, the reactive cysteine
residue within the SNAP domain readily reacts with benzylgua-
nine (BG) to generate a covalent bond while releasing a guanine
group [8]. The DARPin-SNAP constructs were first reduced with
DTT and then reacted with BG-modified oligonucleotides to form
DARPin-SNAP-DNA conjugates in solution [13]. To remove any
remaining unconjugated protein, DARPin-SNAP-DNA conju-
gates were immobilized by hybridization to biotinylated oligonu-
cleotides bound to streptavidin-coated Sepharose beads, in a
manner similar to that used for the purification of antibody-DNA
conjugates, and unconjugated DARPins were washed away. After
restriction digestion with MlyI, the conjugated protein was bound
to cobalt-chelating Dynabeads for his-tag isolation, and excess free
oligonucleotides were then removed by washing. The pure
DARPin-SNAP conjugates were finally eluted in a yield of around
60% out of the starting material.
To monitor the purification, the unpurified G3-SNAP conju-
gation reaction mixtures, eluates after enzymatic digestion, and the
pure G3-SNAP conjugates were subjected to electrophoresis (as
described above) and visualized with protein silver staining
(Figure 2b). G3-SNAP conjugates with S3 block_long oligonucle-
otides (approximately 55 kDa, lane 6) and S3 block oligonucleo-
tides (approximately 50 kDa, lane 7) showed intense bands at
positions expected for the conjugates, in comparison to the
unconjugated G3-SNAP (35 kDa, lane 5). Despite the use of a
three-fold molar excess of oligonucleotides in the conjugation
reaction, some remaining unconjugated G3-SNAP was nonethe-
less seen in the conjugation reaction mixture of G3-SNAP and S3
block_long (Fig. 2b, lane 6) and of G3-SNAP and S3 block
(Fig. 2b, lane 7). The excess of oligonucleotides was also observed
at the bottom of the gel (lane 6 and lane 7). After MlyI digestion,
the eluate (lane 8) was visualized as two bands, corresponding to
the conjugate and excess free S3 block oligonucleotides (which had
been cleaved from excess S3 block_long). This demonstrated
reliable cleavage by the MlyI restriction enzyme and efficient
removal of unconjugated G3-SNAP. Finally, as a result of the two-
step purification, a single, clean band of pure G3-SNAP-DNA
conjugates was seen (lane 9), confirming that both free oligonu-
cleotides and unconjugated G3-SNAP had been removed.
Homogenous – washing-independent – proximity ligation and
extension reactions in solution have proven useful to analyze
proteins in biofluids [9,11]. Solution phase PLA and PEA require
1 ml of sample, and detection depends on dual recognition by
oligonucleotide-modified affinity reagents, followed by DNA
amplification via quantitative PCR. By suitable design of the
DNA strands, it is possible to avoid detection signals from non-
cognate pairs of antibodies or affinity reagents, thus avoiding
increasing problems with cross-reactivity upon multiplexing.
Accordingly, assays are available for up to 96 proteins in the
same reaction, with performance similar to that of individual
assays [16,17]. Since the homogeneous proximity reactions (PLA
and PEA) do not involve any washing steps, it is necessary to use
high-quality probes where both unconjugated antibodies and free
oligonucleotides have been removed, as they would otherwise be
expected to compromise the performance of solution phase
reactions.
To assess the effect of purifying the conjugates, we compared
the performance of pure and unpurified conjugates (probes) in
assays for detection of human interleukin 8 (IL8) protein using
solution phase PLA. The reactions were performed in PLA buffer
alone or with 10% or 50% chicken serum. The purified conjugates
resulted in a limit of detection (LOD) of 0.06 pM, which represents
an approximately 16-fold increased sensitivity of detection over the
unpurified conjugates (0.97 pM) (Figure 3a, Table 1). In complex
samples with 10% or 50% chicken serum, solution phase PLA
probed with pure conjugates demonstrated robust and reproduc-
ible measurement of IL8 protein (Figure 3b, Table 1), and the
chicken serum did not impair the LOD of the assay or its linear
range compared to the corresponding assay in PLA buffer
(Figure 3b).
Next, we sought to determine to what extent unconjugated
antibodies or free oligonucleotides would interfere with the
performance of PLA in solution. We assayed samples containing
10 pM IL8 in PLA buffer using purified conjugates to which
different amounts of unconjugated antibodies specific for IL8 or
unconjugated oligonucleotides (Arm1 and Arm2) had been added.
Unconjugated antibodies at a concentration of 480 pM in assays
using 60 pM conjugates caused a 2-fold decrease in detection
signals (Figure 3c). This is in accordance with the expectation that
unconjugated antibodies would compete with the PLA probes for
binding to their cognate targets and thus reduce detection
efficiency. Free oligonucleotides spiked at a final concentration
of 30 pM into detection reactions with 100 pM IL8 increased assay
background by approximately two Ct units (Figure 3d), indicating
that free oligonucleotides in the reactions cause an increased assay
background and lead to a decreased signal-to-noise ratio by
around 4-fold at these concentrations.
We also investigated the effects of impure probes on in situ
protein detection reactions. The purified DARPin-DNA conju-
gates were used alongside an unpurified DARPin-DNA conjugate
in immuno-RCA to detect HER2 proteins in fixed SK-OV-3 cells
abundantly expressing HER2 protein [18] and BJhTERT cells
lacking the protein [19]. At a probe concentration of 5 nM the
pure G3-SNAP conjugates resulted in a 3-fold lower background
than the unpurified G3-SNAP conjugates in BJhTERT cells
(Figure 4a and b). The increased background from unpurified
probes in BJhTERT cells probably resulted from any free
oligonucleotides that may resist washes. The signal-to-noise ratio,
the number of RCA products in SK-OV-3 cells divided by those in
BJhTERT cells, was lower in assays using unpurified probes
compared to those using purified conjugates (Figure 4a and b).
This is likely a consequence both of unconjugated affinity reagents
(G3-SNAP) blocking target molecules and free oligonucleotides
resistant to washes that may contribute to nonspecific signals. In
order to assess the effect of free affinity reagents in these assays,
G3-SNAP was added back to the purified G3-SNAP conjugates
that were used both in immuno-RCA and in situ PLA. As shown
in Figure 4c, the presence of 40 nM free G3-SNAP greatly
reduced detection signals of HER2 proteins in SK-OV-3 cells. At
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a concentration 64-fold higher than that of the conjugates,
unconjugated DARPins abolished detection of HER2 proteins in
SK-OV-3 cells (Figure 4c). The numbers of detection signals for
HER2 proteins using in situ PLA decreased by a factor of four
when the purified conjugates of either G3-SNAP or 9.01-SNAP
were mixed with an equal concentration of the corresponding free
affinity reagents (Figure 4d), underlining the importance of
purified detection reagents.
In summary, we have demonstrated a generalized and robust
approach for preparing high quality oligonucleotide-modified
affinity reagents, using either antibodies or recombinant binders.
The obtained oligonucleotide-conjugated affinity reagents exhib-
ited greatly improved performance in protein analysis using DNA-
assisted protein detection reactions. The two-step purification on
solid supports is suitable for scalable, high-throughput preparation
of high-grade oligonucleotide-conjugated antibody-based or re-
combinant affinity reagents.
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